Pharma

Your Article Summary

See Latest Articles

Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results
Mpex Pharmaceuticals, 09/11/09

Mpex Pharmaceuticals, Inc. announced positive data from its Phase 2b clinical trial with Aeroquin™ in cystic fibrosis. Trial results showed that nebulized Aeroquin met the primary endpoint of reducing bacterial counts of Pseudomonas aeruginosa in sputum after 28 days of dosing versus placebo.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials